Home / Inspections / 1137171

FDA Inspection 1137171 — NATCO Pharma Limited

NATCO Pharma Limited — FEI 3004540906

The FDA completed an inspection of NATCO Pharma Limited on June 24, 2019 in Rangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rangareddy (India)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1273711 (VAI Thu Jun 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1095772 (VAI Thu Jun 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1011854 (VAI Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 880454 (VAI Fri May 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762119 (NAI Fri Nov 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources